Hill-Rom (NYSE:HRC) Releases FY 2020 Pre-Market Earnings Guidance

Hill-Rom (NYSE:HRC) issued an update on its FY 2020
Pre-Market earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 5.40 for the period, compared to the Thomson Reuters consensus estimate of $5.54.

Shares of NYSE HRC traded down $18.46 during midday trading on Friday, hitting $97.22. 2,814,498 shares of the company’s stock traded hands, compared to its average volume of 458,571. Hill-Rom has a 1 year low of $72.29 and a 1 year high of $117.68. The stock has a market capitalization of $6.47 billion, a price-to-earnings ratio of 44.60, a price-to-earnings-growth ratio of 1.14 and a beta of 0.72. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.22 and a current ratio of 1.52. The firm has a fifty day moving average of $107.95 and a 200 day moving average of $105.06.

Hill-Rom (NYSE:HRC) last released its quarterly earnings results on Friday, July 31st. The medical technology company reported $1.95 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.46 by $0.49. Hill-Rom had a net margin of 5.04% and a return on equity of 22.60%. The firm had revenue of $767.50 million during the quarter, compared to analyst estimates of $749.39 million. During the same quarter in the prior year, the firm earned $1.23 EPS. The business’s revenue for the quarter was up 5.6% compared to the same quarter last year. On average, equities analysts anticipate that Hill-Rom will post 5.4 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, September 18th will be issued a $0.22 dividend. This represents a $0.88 annualized dividend and a yield of 0.91%. The ex-dividend date is Thursday, September 17th. Hill-Rom’s dividend payout ratio is 17.32%.

Several equities research analysts recently issued reports on HRC shares. UBS Group reduced their target price on shares of Hill-Rom from $130.00 to $125.00 and set a buy rating for the company in a report on Monday, May 4th. Barclays reissued a buy rating and issued a $125.00 target price on shares of Hill-Rom in a report on Tuesday, April 14th. Finally, Needham & Company LLC reduced their target price on shares of Hill-Rom from $131.00 to $129.00 and set a buy rating for the company in a report on Friday. Five analysts have rated the stock with a buy rating, Hill-Rom presently has a consensus rating of Buy and a consensus price target of $125.80.

In other Hill-Rom news, SVP Mary Kay Ladone sold 2,278 shares of the company’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $110.00, for a total value of $250,580.00. Following the completion of the transaction, the senior vice president now directly owns 8,163 shares in the company, valued at approximately $897,930. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Paul Sherwood Johnson sold 10,344 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $103.95, for a total value of $1,075,258.80. Following the completion of the transaction, the senior vice president now owns 4,999 shares of the company’s stock, valued at $519,646.05. The disclosure for this sale can be found here. Insiders sold a total of 15,747 shares of company stock valued at $1,657,089 over the last 90 days. 0.65% of the stock is currently owned by corporate insiders.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Featured Article: Dow Jones Industrial Average (DJIA)

Earnings History and Estimates for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.